Cargando…
Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma
Retinoblastoma is the most common intraocular malignancy during childhood. Currently, there is no effective treatment for metastatic retinoblastoma. We investigated potential biomarkers of retinoblastoma by utilizing three datasets from a public database. Functional enrichment analysis, including ge...
Autores principales: | Shi, Ke, Zhu, Xinyue, Wu, Jiali, Chen, Yuhong, Zhang, Jingfa, Sun, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806431/ https://www.ncbi.nlm.nih.gov/pubmed/34482803 http://dx.doi.org/10.1080/21655979.2021.1972080 |
Ejemplares similares
-
Biscuit consumption and diabetic retinopathy incidence in adults in the United States
por: Shi, Ke, et al.
Publicado: (2022) -
Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis
por: Wu, Jiali, et al.
Publicado: (2020) -
Optical Coherence Tomography Angiography Characteristics Serve as Retinal Vein Occlusion Therapeutic Biomarkers for Dexamethasone Intravitreal Implant
por: Shi, Ke, et al.
Publicado: (2021) -
Heavenly HELLS? A potential new therapeutic target for retinoblastoma
por: Zocchi, Loredana, et al.
Publicado: (2020) -
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
por: Lin, Zhuangling, et al.
Publicado: (2023)